维生素B2联合蓝光照射对新生儿黄疸康复进程及肝脏功能的影响研究

Study on the Effects of Vitamin B2 Combined with Blue Light Irradiation on the Recovery Process and Liver Function in Neonatal Jaundice

:-
 
目的:探讨维生素B2(VB2)联合蓝光照射对新生儿黄疸康复进程及肝脏功能的影响。方法:选取2024年5月—2025年10月收治的150例黄疸患儿,应用随机数字表法分为常规组和试验组,每组75例。常规组接受蓝光照射治疗,试验组在常规组基础上口服VB2治疗。比较两组患儿的氧化应激反应[谷胱甘肽过氧化物酶(GSH-Px),8羟基脱氧鸟苷(8-OHdG)、晚期蛋白氧化产物(AOPP)、超氧阴离子(O2-)]、肝脏微循环[血管性血友病因子(vWF)、可溶性血栓调节蛋白(sTM)、肝动脉阻力指数(HA-RI)、门静脉血流速度(PVV)]、胆红素排泄[总胆红素(TBil)、间接胆红素(IBil)]、肝脏功能[丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)]、康复进程[光疗时间、胆红素恢复正常时间、黄疸消退时间、住院康复时间]及治疗安全性。结果:治疗后,试验组的GSH-Px高于常规组,8-OHdG、AOPP、O2-均低于常规组(P<0.05);试验组的vWF、sTM、HA-RI均低于常规组,PVV高于常规组(P<0.05)。试验组的TBil、IBil、ALT、AST分别为(80.52±5.47)μmol/L、(68.52±5.49)μmol/L、(30.25±5.48)U/L、(32.14±5.22)U/L,均低于常规组[(85.19±6.44)μmol/L、(74.37±6.52)μmol/L、(35.29±6.17)U/L、(38.55±6.48)U/L],差异有统计学意义(P<0.05)。试验组的光疗时间、胆红素恢复正常时间、黄疸消退时间、住院康复时间分别为(3.05±0.33)d、(4.22±1.39)d、(5.41±1.27)d、(5.12±0.49)d,均低于常规组[(3.68±0.36)d、(5.36±1.45)d、(6.28±1.33)d、(6.51±0.54)d],差异有统计学意义(P<0.05)。试验组的不良反应发生率与常规组比较,差异无统计学意义(P>0.05)。结论:VB2联合蓝光照射可减轻黄疸患儿的氧化应激反应并改善肝脏微循环,对促进胆红素排泄、改善肝脏功能均有积极影响,在促进患儿康复同时未显著增加治疗风险。其安全性较高,可进一步推广。
Objective: To investigate the effects of vitamin B2 (VB2) combined with blue light irradiation on the recovery process and liver function of neonatal jaundice. Method: 150 children with jaundice admitted from May 2024 to October 2025 were selected and randomly divided into a control group and an experimental group using a random number table method, with 75 cases in each group. The conventional group received blue light irradiation treatment, while the experimental group received oral VB2 treatment on the basis of the conventional group. Compare the oxidative stress response of two groups of children [glutathione peroxidase (GSH Px) higher than the control group, 8-hydroxydeoxyguanosine (8-OHdG), advanced protein oxidation products (AOPP), superoxide anion (O2-)], liver microcirculation [von Willebrand factor (vWF), soluble thrombomodulin (sTM), hepatic artery resistance index (HA-RI), portal vein blood flow velocity (PVV)], bilirubin excretion [total bilirubin (TBil), indirect bilirubin (IBil)], liver function [alanine aminotransferase (ALT), aspartate aminotransferase (AST)], rehabilitation process [phototherapy time, bilirubin recovery time to normal, jaundice regression time]. Hospitalization rehabilitation time and treatment safety. Result: After treatment, the GSH Px levels in the experimental group were higher than those in the control group, while 8-OHdG, AOPP, and O2- levels were lower than those in the control group (P<0.05); The vWF, sTM, and HA-RI of the experimental group were lower than those of the control group, while PVV was higher than that of the control group (P<0.05). The TBil, IBil, ALT, and AST of the experimental group were (80.52 ± 5.47) μ mol/L, (68.52 ± 5.49) μ mol/L, (30.25 ± 5.48) U/L, and (32.14 ± 5.22) U/L, respectively, which were lower than those of the conventional group [(85.19 ± 6.44) μ mol/L, (74.37 ± 6.52) μ mol/L, (35.29 ± 6.17) U/L, (38.55 ± 6.48) U/L], and the difference was statistically significant (P<0.05). The phototherapy time, bilirubin recovery time, jaundice resolution time, and hospital rehabilitation time of the experimental group were (3.05 ± 0.33) days, (4.22 ± 1.39) days, (5.41 ± 1.27) days, and (5.12 ± 0.49) days, respectively, which were lower than those of the conventional group [(3.68 ± 0.36) days, (5.36 ± 1.45) days, (6.28 ± 1.33) days, and (6.51 ± 0.54) days], and the difference was statistically significant (P<0.05). The incidence of adverse reactions in the experimental group was not significantly different from that in the control group (P>0.05). Conclusion: VB2 combined with blue light irradiation can alleviate oxidative stress response and improve liver microcirculation in children with jaundice. It has a positive effect on promoting bilirubin excretion and improving liver function, and does not significantly increase treatment risk while promoting the recovery of children. It has high safety and can be further promoted.

基于快速康复外科理念的医护一体化全程护理对先天性巨结肠手术患儿康复进程、术后疼痛程度、并发症发生率的影响

:-
 
目的 分析基于快速康复外科(ERAS)理念的医护一体化全程护理在先天性巨结肠手术患儿中的护理效果。方法 回顾性选取我院97例HSCR手术患儿(2018年5月—2025年7月)作为研究对象,依照护理模式不同分为对照组(49例)、观察组(48例)。对照组采用常规护理干预,观察组在上述基础上采用基于ERAS理念的医护一体化全程护理。比较2组术后恢复情况、并发症发生率、疼痛程度[FLACC疼痛评分法(FLACC)]、家属照护能力[家属照顾者照顾能力测量表(FCTI)]、家属满意度。结果 干预后,观察组胃管拔除时间、尿管拔除时间、肛管拔除时间、经口进食时间、术后首次排便时间、术后排气时间、肠鸣音恢复时间与住院时长均显著短于对照组,FCTI得分显著低于对照组(P<0.05);干预后,观察组并发症发生率显著低于对照组,家属护理满意度高于对照组(P<0.05);术后3d、7d,观察组FLACC得分均显著低于对照组(P<0.05)。结论 基于ERAS理念的医护一体化全程护理可缓解HSCR手术患儿疼痛程度,提高家属照护能力,降低并发症发生率,促进术后恢复,提升家属满意度。

胃癌患者围手术期口服营养补充管理的临床效果及对营养状态与康复进程的影响研究

:-
 
目的 探讨基于围手术期的口服营养补充(ONS)管理方案对胃癌手术患者的影响。方法 选取2020.1-2025.12本院收治的80例胃癌手术患者,分为观察组和对照组,每组40例。对照组实施围手术期常规膳食指导及肠外营养支持,观察组在对照组基础上实施规范化口服营养补充管理,比较相关指标。结果 术后7d,观察组总蛋白、白蛋白、前白蛋白水平均高于对照组(P<0.001);观察组术后CRP及IL-6水平低于对照组(P<0.001)。观察组术后首次排气时间及住院天数短于对照组(P<0.001);观察组术后并发症总发生率为7.50%,显著低于对照组的25.00%(P<0.05)。结论 胃癌围手术期实施口服营养补充管理,对营养状况的改善,炎症反应的减轻,胃肠功能的恢复,住院时间的缩短,降低并发症风险。

胃癌患者围手术期口服营养补充管理的临床效果及对营养状态与康复进程的影响研究

:-
 
目的 探讨基于围手术期的口服营养补充(ONS)管理方案对胃癌手术患者的影响。方法 选取2020.1-2025.12本院收治的80例胃癌手术患者,分为观察组和对照组,每组40例。对照组实施围手术期常规膳食指导及肠外营养支持,观察组在对照组基础上实施规范化口服营养补充管理,比较相关指标。结果 术后7d,观察组总蛋白、白蛋白、前白蛋白水平均高于对照组(P<0.001);观察组术后CRP及IL-6水平低于对照组(P<0.001)。观察组术后首次排气时间及住院天数短于对照组(P<0.001);观察组术后并发症总发生率为7.50%,显著低于对照组的25.00%(P<0.05)。结论 胃癌围手术期实施口服营养补充管理,对营养状况的改善,炎症反应的减轻,胃肠功能的恢复,住院时间的缩短,降低并发症风险。

胃癌患者围手术期口服营养补充管理的临床效果及对营养状态与康复进程的影响研究

:-
 
目的 探讨基于围手术期的口服营养补充(ONS)管理方案对胃癌手术患者的影响。方法 选取2020.1-2025.12本院收治的80例胃癌手术患者,分为观察组和对照组,每组40例。对照组实施围手术期常规膳食指导及肠外营养支持,观察组在对照组基础上实施规范化口服营养补充管理,比较相关指标。结果 术后7d,观察组总蛋白、白蛋白、前白蛋白水平均高于对照组(P<0.001);观察组术后CRP及IL-6水平低于对照组(P<0.001)。观察组术后首次排气时间及住院天数短于对照组(P<0.001);观察组术后并发症总发生率为7.50%,显著低于对照组的25.00%(P<0.05)。结论 胃癌围手术期实施口服营养补充管理,对营养状况的改善,炎症反应的减轻,胃肠功能的恢复,住院时间的缩短,降低并发症风险。

闭合复位弹性髓内钉固定术对小儿股骨骨折康复进程及关节功能的影响研究

Study on the effect of closed reduction and elastic intramedullary nail fixation on the rehabilitation process and joint function of pediatric femoral fractures

:-
 
目的:探讨闭合复位弹性髓内钉固定术(CR-ESIN)对股骨骨折患儿康复进程及关节功能的影响。方法:回顾性选取2024年4月~2025年6月至我院行内固定术治疗的102例股骨骨折患儿为研究对象,依据手术方案不同,将行CR-ESIN治疗的51例患儿列为CR-ESIN组,将剩余51例行传统切开复位接骨板内固定术(ORIF)治疗的患儿列为ORIF组,比较两组患儿的治疗情况、康复进程,手术并发症发生情况,关节功能恢复情况及内固定物取出阶段负担。结果:在不同手术方案下,CR-ESIN组的手术耗时、术中出血量、术后住院时间、支具使用时间、完全负重时间分别为(60.29±5.44)min、(50.52±5.49)mL、(6.22±1.34)d、(4.15±1.33)周、(6.81±1.34)周,均低于ORIF组[(76.33±8.29)min、(190.48±20.51)mL、(8.17±1.65)d、(6.32±1.48)周、(7.82±2.17)周](t=11.552,47.076,6.552,8.322,2.828;P<0.05)。CR-ESIN组的手术并发症发生率5.88%(3/51)低于ORIF组19.61%(10/51)(x2=4.320;P<0.05)。CR-ESIN组的髋关节前屈活动度、后伸活动度、儿童下肢功能量表(PODCI)评分分别为(132.44±22.52)°、(20.39±4.47)°、(75.14±6.29)分,均高于ORIF组[(120.28±20.37)°、(17.55±3.12)°、(70.31±5.36)分],术后双侧股骨长度差(1.52±0.39)cm低于ORIF组(3.08±0.44)cm(t=2.860,3.721,4.174,18.948;P<0.05)。CR-ESIN组的取出手术切口长度、取出手术耗时、取出手术出血量、再骨折率均低于ORIF组(t/x2=31.706,8.298,38.448,4.883;P<0.05)。结论:CR-ESIN能提高股骨骨折患儿手术效率并降低出血风险,与传统ORIF相比,此术式有利于加快患儿康复进程、降低术后并发症发生率、促进关节功能恢复并减轻内固定物取出阶段负担。
Objective:To explore the effects of closed reduction elastic intramedullary nail fixation (CR-ESIN) on the rehabilitation process and joint function of children with femoral fractures.Methods:A retrospective study was conducted on 102 children with femoral fractures who underwent internal fixation surgery in our hospital from April 2024 to June 2025. Based on different surgical plans, 51 children who underwent CR-ESIN treatment were included in the CR-ESIN group, and the remaining 51 children who underwent traditional open reduction plate internal fixation (ORIF) treatment were included in the ORIF group. The treatment status, rehabilitation process, incidence of surgical complications, joint function recovery, and burden during the removal of internal fixation materials were compared between the two groups of children.Results:Under different surgical plans, the surgical time, intraoperative blood loss, postoperative hospitalization time, brace use time, and complete weight-bearing time of the CR-ESIN group were (60.29 ± 5.44) min, (50.52 ± 5.49) mL, (6.22 ± 1.34) d, (4.15 ± 1.33) weeks, and (6.81 ± 1.34) weeks, lower than the ORIF group [(76.33 ± 8.29) min, (190.48 ± 20.51) mL, (8.17 ± 1.65) d, (6.32 ± 1.48) weeks, and (7.82 ± 2.17) weeks] (t=11.552,47.076,6.552,8.322,2.828; P<0.05). The incidence of surgical complications in the CR-ESIN group was 5.88% (3/51) lower than the ORIF group 19.61% (10/51) (x2=4.320; P<0.05). The hip flexion range of motion, extension range of motion, and PODCI scores of the CR-ESIN group were (132.44 ± 22.52) °, (20.39 ± 4.47) °, and (75.14 ± 6.29) points, higher than the ORIF group [(120.28 ± 20.37) °, (17.55 ± 3.12) °, and (70.31 ± 5.36) points]. The length difference between the bilateral femurs was (1.52 ± 0.39) cm, which was lower than the ORIF group (3.08 ± 0.44) cm (t=2.860,3.721,4.174,18.948; P<0.05). The length of the surgical incision, the duration of the extraction surgery, the amount of bleeding during the extraction surgery, and the rate of re fracture in the CR-ESIN group were all lower than the ORIF group (t/x2=31.706,8.298,38.448,4.883; P<0.05).Conclusion:CR-ESIN can improve the surgical efficiency and reduce the risk of bleeding in children with femoral fractures. Compared with traditional ORIF, this procedure is beneficial for accelerating the recovery process of children, reducing the incidence of postoperative complications, promoting joint function recovery, and reducing the burden of internal fixation removal stage.
论著

基于儿童早期预警评分的分级干预模式促进重症肺炎患儿康复进程及对呼吸功能的影响

The effect of graded intervention mode based on Pediatric Early Warning Score on the recovery process and respiratory function of children with severe pneumonia

:929-933
 
目的 研究基于儿童早期预警评分(PEWS)的分级干预模式促进重症肺炎患儿康复进程及对呼吸功能的影响。方法 回顾性分析2021年4月—2023年4月我院收治的100例重症肺炎患儿临床资料。将其按照干预方式的差异分为研究组(n=50)及对照组(n=50)。对照组选用常规干预,研究组则于对照组基础上增加基于PEWS的分级干预。对比两组康复进程(相关指标涵盖症状持续时长及住院天数)、呼吸功能(涵盖通气流速、每分钟最大通气量、肺活量、用力肺活量及深吸气量)、并发症发生情况(涵盖呼吸机相关性肺炎、肺大疱及胸膜炎)、患儿家属满意度。结果 研究组各项症状持续时长及住院天数均短于对照组(均P<0.05)。研究组各项呼吸功能指标水平均高于对照组(均P<0.05)。两组各项并发症发生率对比差异无统计学意义(P>0.05)。研究组患儿家属满意度高于对照组(96.00% vs 82.00%,P<0.05)。结论 基于PEWS的分级干预模式促进重症肺炎患儿康复进程的效果较佳,且能改善呼吸功能,提高患儿家属满意度。
Objective To study the effect of graded intervention mode based on Pediatric Early Warning Score(PEWS)on the recovery process and respiratory function of children with severe pneumonia.Methods The clinical data of 100 children with severe pneumonia treated in our hospital from April 2021 to April 2023 were retrospectively analyzed.Those children were divided into study group(n=50)and control group(n=50)according to the difference of intervention methods.Conventional intervention was used in the two groups,and PEWS-based graded intervention was added to the study group.The two groups were compared with each other in terms of recovery process(including duration of symptoms and length of stay),respiratory function(including ventilation velocity,maximum volume per minute,vital capacity,forced vital capacity and deep inspiratory capacity),complications(including ventilators associated pneumonia,bullosa and pleurisy),and family member satisfaction.Results The duration of symptoms and hospitalization days in the study group were shorter than those in the control group(all P<0.05).The levels of respiratory function indexes in study group were higher than those in control group(all P<0.05).There was no significant difference in the incidence of complications between the two groups(P>0.05).The satisfaction of family member in the study group was higher than that in the control group(96.00% vs 82.00%)(P<0.05).Conclusions The PEWS based graded intervention model has a good effect on promoting the rehabilitation process of children with severe pneumonia,and can improve respiratory function,and increase the satisfaction of family member of children with severe pneumonia.
论著

麦默通微创旋切术加置引流对乳腺良性肿物患者术后康复进程及并发症发生率的影响

Effect of minimally invasive excision by Mammotome with drainage on the postoperative recovery process and complication rate of patients with benign breast masses

:87-91
 
目的 探究麦默通(Mammotome)微创旋切术加置引流对乳腺良性肿物患者术后疼痛、炎性应激指标及并发症的影响。方法 选取本院2020年1月—2022年1月收治的100例乳腺良性肿物患者,简单随机法进行分组,每位患者赋予1位随机数,1~51号为实验组,采用Mammotome微创旋切术加置引流,52~100号为对照组,实施Mammotome微创旋切术。对比2组治疗效果、围术期指标、术前及术后1 d、3 d疼痛程度(NRS评分)、术前及术后3 d炎性应激指标及并发症情况。结果 2组病灶清除率(100.00%、97.96%)、并发症发生率(3.92%、16.32%)间无差异(P>0.05);相较于对照组,实验组手术时间较长,残腔积液较少,住院时间较短(P<0.05);术后1 d、3 d实验组NRS评分低于对照组(P<0.05);术后3 d 2组C反应蛋白、白介素-6、白介素-1β、降钙素原水平较术前上升,且实验组上升幅度小于对照组(P<0.05)。结论 Mammotome微创旋切术加置引流治疗乳腺良性肿物能减少残腔积液,降低炎症反应程度,有助于术后切口愈合,缓解术后疼痛,且不增加并发症风险。
Objective To investigate the effect of Mammotome minimally invasive excision with drainage on postoperative pain,inflammatory stress indexes and complications in patients with benign breast tumors.Methods A total of 100 patients with benign breast tumors admitted to our hospital from January 2020 to January 2022 were selected and grouped by simple random method,each patient was assigned a random number.Patients No.1 to No.51 were included in the experimental group,treated with Mammotome minimally invasive excision with drainage.Patients No.52 to No.100 were included in the control group,treated with Mammotome minimally invasive excision.The treatment effect,perioperative indicators,pain level(NRS score)and inflammatory stress indexes before and 1st and 3rd days after operation and complications were compared between the two groups.Results There were no significant differences in the lesion clearance rate(100.00% vs 97.96%)and the complication rate(3.92% vs 16.32%)between the two groups(P>0.05).Compared with the control group,the experimental group had longer operation time,less residual cavity liquid and shorter hospital stay(P<0.05).The NRS score of the experimental group was lower than that of the control group at 1st and 3rd days after operation(P<0.05).On the third day after operation,the levels of C-reactive protein,interleukin- 6,interleukin-1β and procalcitonin in the two groups were increased compared with those before operation,and the increase in the experimental group was smaller than that in the observation group(P<0.05).Conclusions Mammotome minimally invasive excision with drainage in the treatment of benign breast tumors can reduce residual cavity fluid accumulation,reduce the degree of inflammatory response,help postoperative incision healing,relieve postoperative pain,and without increasing the risk of complications.
出版者信息








《广州医药》公众号